Cell and gene therapy venture capital and public funding deal count
RecordSTO-01M2KJ7XCF-5037JCNPDK-KT7NNJ
Global · 2021
Cell and gene therapy venture capital and public funding deal count worldwide was 127 in 2021 (IQVIA).
Cell and gene therapy venture capital and public funding deal count: every country and year, and how it is measured
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
The total number of deals peaked at 127 in 2021 — 57% higher than in 2020 — dropped 24% in 2022 to 97 deals, and remained flat in 2023 at 96 deals, although still up 19% from 2020.
Checked: the figure 127is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IQVIA Institute. (2021). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ
Other formats: MLA, Chicago, BibTeX
- MLA
- IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2021, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ.
- Chicago
- IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2021. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ.
- BibTeX
- @misc{iqvia2021cellkt7nnj, author = {{IQVIA Institute}}, title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios}, year = {2021}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Research and companies
- Report
- Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios
- Type
- Press release
- Published
- —
- Locator
- Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Permanent URL
- /stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ